As Women’s Health Week comes to a close, check out some of our recent women’s health coverage. Dive deep into everything from skin care myths to reproductive care access.
Maintenance Use of ADHD Therapies May Be Safe in Pregnancy
Continued methylphenidate or atomoxetine use may be safe, but additional studies are needed.
Evaluating the Safety of Tetracycline Use During the First Trimester of Pregnancy
As “therapeutic orphans,” pregnant women and their health care providers must balance the benefits of treatment with the risk of fetal harm.
GoodRx, Opill Partner on OTC Delivery Program to Address Gaps in Access
GoodRx’s new e-commerce service further expands access to Opill by allowing consumers to order the birth control directly to their homes without a prescription.
Women with Delayed Menopause May Face Increased Risk of Asthma
Women experiencing later menopause may face a heightened risk of asthma, underscoring the possible role of estrogen in the development of the condition.
Hormonal Contraceptive Prescribing Benefits Patients, Pharmacies | NCPA 2024
With nearly 7 million women living in a health care desert, pharmacists can provide crucial reproductive care services.
FDA Approves Sulopenem Etzadroxil and Probenecid for Uncomplicated UTIs
The FDA has approved just the second treatment for uncomplicated urinary tract infections (UTIs) in the last 2 decades.